Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nu Holdings Ltd (NU) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Nu Holdings LtdTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Nu Holdings Ltd vs Health Care Select Sector SPDR Fund — how do they compare? Nu Holdings Ltd trades at $14.39 (market cap $67.58B), while Health Care Select Sector SPDR Fund trades at $160.31. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Nu Holdings Ltd nearer its low. Which is the better fit depends on your goals.

NUXLV
Market Cap
$67.58B
Sector
Financials
52-Week High
$18.76$164.48
52-Week Low
$11.60$129.01

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nu Holdings Ltd

NU stock trades at $14.39, up 5.89% in the last session, with a bullish technical signal from moving averages and strong fundamental growth. Revenue surged from $3.0B in 2022 to $10.63B in 2025, while net income turned positive to $2.87B. Recent news highlights expansion in Brazil and Mexico, including a new banking license, supporting continued growth momentum.

Outlook remains positive with a consensus price target of $14.98, though risks include rapid credit expansion and increased provisions. The stock offers exposure to Latin America's digital banking growth but faces execution risks in new markets and competitive pressures. Analyst sentiment is bullish with 55% buy ratings.

Health Care Select Sector SPDR Fund

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nu Holdings Ltd

Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.

Read more on NU

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV